Cargando…
A Review of Anti-Angiogenic Targets for Monoclonal Antibody Cancer Therapy
Tumor angiogenesis is a key event that governs tumor progression and metastasis. It is controlled by the complicated and coordinated actions of pro-angiogenic factors and their receptors that become upregulated during tumorigenesis. Over the past several decades, vascular endothelial growth factor (...
Autores principales: | Kong, Deok-Hoon, Kim, Mi Ra, Jang, Ji Hye, Na, Hee-Jun, Lee, Sukmook |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5578174/ https://www.ncbi.nlm.nih.gov/pubmed/28817103 http://dx.doi.org/10.3390/ijms18081786 |
Ejemplares similares
-
Emerging Roles of Vascular Cell Adhesion Molecule-1 (VCAM-1) in Immunological Disorders and Cancer
por: Kong, Deok-Hoon, et al.
Publicado: (2018) -
Cell Surface GRP94 as a Novel Emerging Therapeutic Target for Monoclonal Antibody Cancer Therapy
por: Kim, Ji Woong, et al.
Publicado: (2021) -
TSPAN8 as a Novel Emerging Therapeutic Target in Cancer for Monoclonal Antibody Therapy
por: Heo, Kyun, et al.
Publicado: (2020) -
Recent Advances in Monoclonal Antibody Therapy for Colorectal Cancers
por: Hwang, Kyusang, et al.
Publicado: (2021) -
Correction: Kim et al. Cell Surface GRP94 as a Novel Emerging Therapeutic Target for Monoclonal Antibody Cancer Therapy. Cells 2021, 10, 670
por: Kim, Ji Woong, et al.
Publicado: (2021)